Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yukiyasu Arakawa"'
Autor:
Tatsushi Ishimoto, Yukiyasu Arakawa, Secil Vural, Julia Stöhr, Sigrid Vollmer, Adrian Galinski, Katherina Siewert, Geraldine Rühl, Yuri Poluektov, Marc Delcommenne, Orsolya Horvath, Mengwen He, Burkhard Summer, Ralf Pohl, Rehab Alharbi, Klaus Dornmair, Akiko Arakawa, Jörg C. Prinz
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionPsoriasis is a T-cell mediated autoimmune skin disease. HLA-C*06:02 is the main psoriasis-specific risk gene. Using a Vα3S1/Vβ13S1 T-cell receptor (TCR) from a lesional psoriatic CD8+ T-cell clone we had discovered that, as an underlyin
Externí odkaz:
https://doaj.org/article/9d40d63e9367413db27f9f40a57c9739
Publikováno v:
Allergology International, Vol 70, Iss 1, Pp 156-158 (2021)
Externí odkaz:
https://doaj.org/article/d4b892b2ed9b4e4a86386d04bfb57a15
Publikováno v:
Allergology International, Vol 69, Iss 3, Pp 480-482 (2020)
Externí odkaz:
https://doaj.org/article/8d832dd3d4fd4ec8872b8e837ea137e1
Autor:
Risa Tamagawa‐Mineoka, Mayumi Ueta, Yukiyasu Arakawa, Mari Nakanishi, Hiromi Nishigaki, Norito Katoh
Publikováno v:
Experimental Dermatology. 32:715-717
Publikováno v:
International Journal of Trichology. May/Jun2022, Vol. 14 Issue 3, p112-114. 3p.
Autor:
Daniela Hartmann, Yukiyasu Arakawa, Aylin Okçu Heper, Sigrid Vollmer, K. Kerl, Ayşe Boyvat, A. Karal-Öktem, A. Arakawa, Jörg C. Prinz, P. Ertop Doğan, U. Puchta, M. He, Seçil Vural
Publikováno v:
British Journal of Dermatology
Background: Behcet disease (BD) presents with lymphocytic and neutrophilic vasculitis of unknown aetiology. HLA-B*51, the endoplasmic reticulum aminopeptidase 1 (ERAP1), and interleukin 23 receptor (IL23R)/IL12R are genetic risk factors. IL-23 regula
Publikováno v:
International journal of dermatology.
Autor:
Makoto Wada, Norito Katoh, Miho Tsutsumi, Yuka Kaneko, Mai Kanemaru, Taro Isohisa, Takahiro Arita, Jun Asai, Eiichi Konishi, Yukiyasu Arakawa
Publikováno v:
Journal of Cutaneous Pathology. 47:584-591
BACKGROUND Sarcoidosis is a chronic and systemic inflammatory disease, in which patients present with noncaseating epithelioid granulomas. Cutaneous lesions of sarcoidosis develop in 9% to 35% of all sarcoidosis patients and comprise various clinical